-
Review
January 5, 2024
- Comprehensive approach to controlling chronic hepatitis B in China
- Shan Shan, Xinyan Zhao, Jidong Jia
- Clin Mol Hepatol. 2024;30(2):135-143.
Review
January 5, 2024
Original Article
December 29, 2023
Original Article
January 8, 2024
Original Article
January 8, 2024
Original Article
January 24, 2024
Original Article
January 26, 2024
Original Article
January 26, 2024
This archive contains links to the full-text of all issues of Clin Mol Hepatol.
First decision
09 Days
Publication after acceptance
04 Days
*Last 12 months
Viewed By 5348 |
Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment |
Viewed By 5297 |
MAFLD: How is it different from NAFLD? |
Viewed By 5193 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Viewed By 3886 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma |
Viewed By 3841 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Cited By 114 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Cited By 103 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma |
Cited By 76 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Cited By 65 |
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach |
Cited By 52 |
MAFLD: How is it different from NAFLD? |